Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)
type: MedicalStudy
description: A Phase I Trial of Oral Deforolimus (AP23573; MK-8669), an mTOR Inhibitor, in Combination With Bevacizumab for Patients With Advanced Cancers
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2008-10
end date: 2010-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00781846
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Merck Sharp & Dohme LLC
study subject: Solid Tumor
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Solid Tumor

AI Analytics
type: Organization